S T Nawrocki
Overview
Explore the profile of S T Nawrocki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
350
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kelly K, Espitia C, Zhao W, Wu K, Visconte V, Anwer F, et al.
Leukemia
. 2017 Aug;
32(1):230-233.
PMID: 28832023
No abstract available.
2.
Visconte V, Przychodzen B, Han Y, Nawrocki S, Thota S, Kelly K, et al.
Leukemia
. 2016 Oct;
31(2):505-510.
PMID: 27773925
No abstract available.
3.
Visconte V, Nawrocki S, Espitia C, Kelly K, Possemato A, Beausoleil S, et al.
Leukemia
. 2015 Sep;
30(5):1190-4.
PMID: 26369982
No abstract available.
4.
Carew J, Espitia C, Zhao W, Kelly K, Coffey M, Freeman J, et al.
Cell Death Dis
. 2013 Jul;
4:e728.
PMID: 23868061
Activating mutation of KRas is a genetic alteration that occurs in the majority of pancreatic tumors and is therefore an ideal therapeutic target. The ability of reoviruses to preferentially replicate...
5.
Mahalingam D, Espitia C, Medina E, Esquivel 2nd J, Kelly K, Bearss D, et al.
Br J Cancer
. 2011 Oct;
105(10):1563-73.
PMID: 22015557
Background: Upregulation of PIM kinase expression has been reported in many malignancies, suggesting that inhibition of PIM kinase activity may be an attractive therapeutic strategy. We hypothesised that inhibition of...
6.
Kelly K, Espitia C, Mahalingam D, Oyajobi B, Coffey M, Giles F, et al.
Oncogene
. 2011 Oct;
31(25):3023-38.
PMID: 22002308
Oncolytic virotherapy with reovirus has demonstrated anti-cancer activity and minimal toxicity in clinical trials, but the mechanisms underlying these effects have not been fully elucidated. Reolysin, a proprietary formulation of...
7.
Mahalingam D, Swords R, Carew J, Nawrocki S, Bhalla K, Giles F
Br J Cancer
. 2009 Apr;
100(10):1523-9.
PMID: 19401686
Heat-shock proteins (HSPs) are molecular chaperones that regulate protein folding to ensure correct conformation and translocation and to avoid protein aggregation. Heat-shock proteins are increased in many solid tumours and...
8.
Nawrocki S, Drake K, Watson C, Foster G, Maier K
Arch Environ Contam Toxicol
. 2005 Mar;
48(3):344-50.
PMID: 15750776
2-(Thiocyanomethylthio)benzothiazole (TCMTB) is a biocide used in the leather, pulp and paper, and water-treatment industries. TCMTB may enter aquatic ecosystems during its manufacture and use. TCMTB is environmentally unstable; therefore,...
9.
Carew J, Nawrocki S, Xu R, Dunner K, McConkey D, Wierda W, et al.
Leukemia
. 2004 Oct;
18(12):1934-40.
PMID: 15483672
B cell chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western hemisphere, yet many biological and molecular features of the disease remain undefined. CLL cells generate...